French pharma company develops anti-dengue vaccine

For the first time in 50 years of dengue research, the first safe, effective and affordable anti-dengue vaccine in the world could be out commercially in the country by end of next year. This was announced by Guillaume Leroy, vice president and dengue vaccine head of France-based pharmaceutical company Sanofi Pasteur, which bared the development of the vaccine at the opening-day program of the Fourth Association of Southeast Asian Nations (Asean) Dengue Day summit. Asean Dengue Day is an advocacy event held every June 15 starting 2011 to increase public awareness of dengue; to mobilize resources for its prevention and control; and to demonstrate the region’s commitment to tackling the disease. Leroy, who gave updates on clinical dengue-vaccine development, said, “We plan to submit the information for the license in early 2015, and as soon as regulatory agencies of the different countries will give the license…it will be available in the market by...